[go: up one dir, main page]

SE9300971D0 - Hudvaardskomposition - Google Patents

Hudvaardskomposition

Info

Publication number
SE9300971D0
SE9300971D0 SE19939300971A SE9300971A SE9300971D0 SE 9300971 D0 SE9300971 D0 SE 9300971D0 SE 19939300971 A SE19939300971 A SE 19939300971A SE 9300971 A SE9300971 A SE 9300971A SE 9300971 D0 SE9300971 D0 SE 9300971D0
Authority
SE
Sweden
Prior art keywords
cyclodextrin
conjugate
vitamin
beta
derivative
Prior art date
Application number
SE19939300971A
Other languages
English (en)
Inventor
*Wadstein Jan
*Samuelsson Mats
Original Assignee
Jan Wadstein
Mats Samuelsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Wadstein, Mats Samuelsson filed Critical Jan Wadstein
Priority to SE19939300971A priority Critical patent/SE9300971D0/sv
Publication of SE9300971D0 publication Critical patent/SE9300971D0/sv
Priority to PCT/SE1994/000235 priority patent/WO1994021225A1/en
Priority to AU63884/94A priority patent/AU6388494A/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/738Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986Milk; Derivatives thereof, e.g. butter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE19939300971A 1993-03-24 1993-03-24 Hudvaardskomposition SE9300971D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE19939300971A SE9300971D0 (sv) 1993-03-24 1993-03-24 Hudvaardskomposition
PCT/SE1994/000235 WO1994021225A1 (en) 1993-03-24 1994-03-17 Skin care composition
AU63884/94A AU6388494A (en) 1993-03-24 1994-03-17 Skin care composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939300971A SE9300971D0 (sv) 1993-03-24 1993-03-24 Hudvaardskomposition

Publications (1)

Publication Number Publication Date
SE9300971D0 true SE9300971D0 (sv) 1993-03-24

Family

ID=20389341

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939300971A SE9300971D0 (sv) 1993-03-24 1993-03-24 Hudvaardskomposition

Country Status (3)

Country Link
AU (1) AU6388494A (sv)
SE (1) SE9300971D0 (sv)
WO (1) WO1994021225A1 (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5653971A (en) * 1995-06-30 1997-08-05 The Gillette Company Shaving aid composite with an inclusion complex of a skin-soothing agent and a cyclodextrin
DE19619990A1 (de) * 1996-05-17 1997-11-20 Charlotte Adler Verfahren zur Herstellung von Kolostralmilchprodukten sowie deren Verwendung
JP3940209B2 (ja) * 1996-11-14 2007-07-04 株式会社資生堂 可溶化化粧料
SE520645C2 (sv) * 1996-11-15 2003-08-05 Interhealth Ab Terapeutiska och kosmetiska kompositioner, deras användning och metod för framställning därav
DE19713092A1 (de) * 1997-03-27 1998-10-01 Wacker Chemie Gmbh Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung
SE9801647D0 (sv) * 1998-05-12 1998-05-12 Interhealth Ab Therapeutic composition
KR100404868B1 (ko) * 2000-03-28 2003-11-15 김삼 안정한 레티놀 팔미테이트 및 그를 함유하는 화장료 조성물
NO310176B1 (no) * 2000-11-13 2001-06-05 Wadlund As Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne
DE10257246A1 (de) * 2002-12-07 2004-06-24 Beiersdorf Ag Kosmetikum gegen Gesichtsglanz
EP1641458A2 (en) * 2002-12-27 2006-04-05 Schering Aktiengesellschaft Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors
NO326950B1 (no) * 2006-09-20 2009-03-16 Pharma Medico Res Ltd Kombinasjon av et glukokortikoid og et β-syklodekstrin konjugert vitamin A derivat-kompleks
NO20074043L (no) * 2007-08-06 2009-02-09 Spero As Hudpleiende middel
US8410079B2 (en) * 2010-08-06 2013-04-02 Island Kinetics Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion
US20140094433A1 (en) * 2012-10-02 2014-04-03 Allergan, Inc. Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes
US20140234433A1 (en) * 2013-02-15 2014-08-21 Nicholas V. Perricone Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
FR2628973B1 (fr) * 1988-03-25 1990-11-16 Gattefosse Ets Sa Composition cosmetique ou pharmaceutique a usage cutane, et procede pour la preparation d'une telle composition
AU616571B2 (en) * 1988-10-28 1991-10-31 Shiseido Company Ltd. Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
FR2647015B1 (fr) * 1989-05-17 1994-05-06 Cird Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique
LU87843A1 (fr) * 1990-11-15 1992-08-25 Cird Galderma Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique

Also Published As

Publication number Publication date
WO1994021225A1 (en) 1994-09-29
AU6388494A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
SE9300971D0 (sv) Hudvaardskomposition
CY1109869T1 (el) Παραγωγη πεπτιδιων και φαρμακευτικα αποδεκτων αλατων τους, τροποι συνθεσης, χρησης και φαρμακευτικης συνθεσης
FI956014A0 (sv) Användning av nona- och dekapeptider för framställning av läkemedel för behandling av AIDS
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
EP0504938A3 (en) Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
AU2905092A (en) Pharmaceutical dipeptide compositions and methods of use thereof
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
GR3019625T3 (en) Topically administered compositions based on high molecular weight hyaluronic acid for treating inflammations of the oral cavity, and for oral cavity hygiene and cosmetic treatment
PT998287E (pt) Utilizacao de levobupivacaina
MX9708800A (es) Compuestos biciclicos aromaticos.
GB9103764D0 (en) Compositions
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
AU6924698A (en) Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
TR200102512T2 (tr) Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
AU3401093A (en) Therapeutic agent for threatened abortion
EP0821969A3 (en) Medicinal Composition comprising TCF-II
EE9700231A (et) Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks